Agreements reached under this partnership
Business AlliancesThe impact of sales of this product on consolidated net sales is expected to be immaterial. Although the impact of this matter on the Company’s results is expected to be immaterial, the product is a high-value-added product for medical facilities, primarily veterinary hospitals, and is expected to make a significant contribution to the Company’s results over the medium to long term as one of its core products.
| Item | Details |
|---|---|
| Name of alliance partner | カルテック株式会社, Veterinarians affiliated with the Company |
| Alliance partner's business activities | Not disclosed, Veterinary medical services |
| Type of alliance | Business Alliances |
| Alliance start date | 8 May 2026 |
| Impact on Business Performance | The impact of sales of this product on consolidated net sales is expected to be immaterial. Although the impact of this matter on the Company’s results is expected to be immaterial, the product is a high-value-added product for medical facilities, primarily veterinary hospitals, and is expected to make a significant contribution to the Company’s results over the medium to long term as one of its core products. |
Items this document does not state (18)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The product combines 飛鳥メディカル’s medical laser technology, カルテック’s photocatalytic technology, and expertise from veterinary clinical settings to address odor control and infection prevention in veterinary medical facilities.